Immunization, Hib3 in East Asia & Pacific
East Asia & Pacific: Immunization, Hib3 was 44.7% in 2024. ◆ Volatile
Immunization, Hib3 in East Asia & Pacific, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in East Asia & Pacific is 44.7%, measured in 2024.
The figure is up 1.9% on the previous year and up 61.7% over ten years.
Over the whole period, immunization, hib3 in East Asia & Pacific peaked at 44.8% in 2022 and was at its lowest, 0.0%, in 1990.
That places East Asia & Pacific 41st out of 43 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in East Asia & Pacific, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.8% | — |
| 1998 | 0.9% | +5.3% |
| 1999 | 0.9% | +8.1% |
| 2000 | 1.0% | +5.3% |
| 2001 | 1.0% | +3.9% |
| 2002 | 1.1% | +1.7% |
| 2003 | 1.1% | +0.7% |
| 2004 | 2.3% | +118.0% |
| 2005 | 2.6% | +12.7% |
| 2006 | 2.7% | +5.0% |
| 2007 | 2.8% | +2.2% |
| 2008 | 3.0% | +6.7% |
| 2009 | 3.4% | +14.1% |
| 2010 | 7.7% | +127.0% |
| 2011 | 13.5% | +74.9% |
| 2012 | 19.9% | +47.4% |
| 2013 | 20.8% | +4.7% |
| 2014 | 27.7% | +32.9% |
| 2015 | 35.8% | +29.3% |
| 2016 | 36.8% | +2.8% |
| 2017 | 36.7% | -0.0% |
| 2018 | 33.7% | -8.3% |
| 2019 | 36.9% | +9.5% |
| 2020 | 37.0% | +0.4% |
| 2021 | 36.4% | -1.8% |
| 2022 | 44.8% | +23.1% |
| 2023 | 43.9% | -2.0% |
| 2024 | 44.7% | +1.9% |
Biggest year-on-year movements
Years where Immunization, Hib3 in East Asia & Pacific changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +127.0% | 3.4% | 7.7% |
| 2004 | +118.0% | 1.1% | 2.3% |
| 2011 | +74.9% | 7.7% | 13.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.3% | 0.0% | 0.9% | 10 |
| 2000s | 2.1% | 1.0% | 3.4% | 10 |
| 2010s | 26.9% | 7.7% | 36.9% | 10 |
| 2020s | 41.3% | 36.4% | 44.8% | 5 |
More health data for East Asia & Pacific
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate -0.7993 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0324 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate -0.9374 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0365 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0412 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in East Asia & Pacific?
- Immunization, hib3 in East Asia & Pacific was 44.7% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in East Asia & Pacific?
- The highest recorded value was 44.8% in 2022.
- What is the lowest immunization, hib3 recorded in East Asia & Pacific?
- The lowest recorded value was 0.0% in 1990.
- How does East Asia & Pacific rank for immunization, hib3?
- East Asia & Pacific ranks 41st out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in East Asia & Pacific?
- Over the last ten years it is up 61.7%. The long-run trend across the full record is volatile.
- Where does this East Asia & Pacific data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.